Department of Neurosurgery, University Medical Center Schleswig-Holstein UKSH, Kiel, Germany.
Exp Cell Res. 2010 May 15;316(9):1553-66. doi: 10.1016/j.yexcr.2010.02.018. Epub 2010 Feb 23.
The transmembrane chemokine CX3CL1 and its receptor CX3CR1 are thought to be involved in the trafficking of immune cells during an immune response and in the pathology of various human diseases including cancer. However, little is known about the expression and function of CX3CR1 in human glioma-infiltrating microglia/macrophages (GIMs), representing the major cellular stroma component of highly malignant gliomas. Here, we show that CX3CR1 is overexpressed at both the mRNA and protein level in solid human astrocytomas of different malignancy grades and in glioblastomas. CX3CR1 was localized in ionized calcium-binding adapter molecule 1 (Iba1) and CD11b/c positive GIMs in situ as shown by fluorescence microscopy. In accordance with this, freshly isolated human GIM-enriched fractions separated by CD11b MACS technology displayed high Iba1 and CX3CR1 mRNA expression levels in vitro. Moreover, cultured human GIMs responded to CX3CL1-triggered activation of CX3CR1 with adhesion and migration in vitro. Besides an increase in motility, CX3CL1 also enhanced expression of matrix metalloproteases 2, 9, and 14 in GIM fractions in vitro. These data indicate that the CX3CL1/CX3CR1 system has a crucial tumor-promoting role in human glioblastomas via its impact on glioma-infiltrating immune subsets.
细胞间趋化因子 CX3CL1 及其受体 CX3CR1 被认为参与免疫反应期间免疫细胞的迁移以及包括癌症在内的各种人类疾病的发病机制。然而,人们对 CX3CR1 在人类脑胶质瘤浸润的小胶质细胞/巨噬细胞(GIM)中的表达和功能知之甚少,GIM 是高度恶性神经胶质瘤的主要细胞基质成分。在这里,我们发现 CX3CR1 在不同恶性程度的实体人星形细胞瘤和胶质母细胞瘤中的 mRNA 和蛋白水平均过度表达。荧光显微镜显示,CX3CR1 定位于原位的离子钙结合衔接分子 1(Iba1)和 CD11b/c 阳性 GIM 上。与此一致的是,通过 CD11b MACS 技术分离的新鲜分离的富含人 GIM 的级分在体外显示出高的 Iba1 和 CX3CR1 mRNA 表达水平。此外,培养的人 GIM 对 CX3CL1 触发的 CX3CR1 激活做出反应,在体外表现出黏附和迁移。除了运动性增加外,CX3CL1 还增强了体外 GIM 级分中基质金属蛋白酶 2、9 和 14 的表达。这些数据表明,CX3CL1/CX3CR1 系统通过其对浸润性胶质瘤免疫亚群的影响,在人类胶质母细胞瘤中具有关键的促肿瘤作用。
Exp Cell Res. 2010-2-23
Eur Cytokine Netw. 2010-3
J Neuroimmunol. 2010-7-13
Acta Neuropathol Commun. 2025-6-28
NPJ Precis Oncol. 2025-5-2
Cancers (Basel). 2025-2-26
Onco Targets Ther. 2025-1-18
Adv Neurobiol. 2024